Trials / Not Yet Recruiting
Not Yet RecruitingNCT05172284
Registry and Monitoring of ImmuNe-mediated Inflammatory Diseases
Registry and Monitoring of ImmuNe-mediated Inflammatory Diseases (IMIDs) REMIND Study
- Status
- Not Yet Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 2,000 (estimated)
- Sponsor
- I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
Formation of a registry of IMID patients to assess the evolution of resistance to conventional and target therapies. This aim is achieved by evaluating the achievement of PASI 50 and PASI 75 scores at week 16 from the start of treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Questionnaires | This is a collection of data from normal clinical routine: patients will be asked to record the assessments they undergo during their course of treatment, without changing clinical practice in any way. Data inherent to the following procedures will be collected: examinations, laboratory tests, imaging tests, questionnaires and rating scales. |
Timeline
- Start date
- 2022-02-01
- Primary completion
- 2023-02-01
- Completion
- 2026-12-01
- First posted
- 2021-12-29
- Last updated
- 2022-01-11
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT05172284. Inclusion in this directory is not an endorsement.